+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genmab AS - logo

Genmab is a leading biotechnology company that focuses on developing innovative antibody products. Arzerra is the company’s first marketed antibody and is approved to treat chronic lymphocytic leukemia (CLL) patients in all major markets. Another product, Darzalex, has been approved in the United States for the treatment of patients with multiple myeloma. Genmab was founded in Copenhagen, Denmark in 1999 and employs around 200 people.

Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
Large Molecule Drug Substance CDMO Market Size, Share & Industry Trends Analysis Report By Application (Mammalian, Microbial and Others), By Service (Contract Manufacturing and Contract Development), By End-user, By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Large Molecule Drug Substance CDMO Market Size, Share & Industry Trends Analysis Report By Application (Mammalian, Microbial and Others), By Service (Contract Manufacturing and Contract Development), By End-user, By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • December 2022
  • 278 Pages
  • Global
From
The State of the Biopharmaceutical Industry 2024 Edition - Product Thumbnail Image

The State of the Biopharmaceutical Industry 2024 Edition

  • Report
  • December 2023
  • 110 Pages
  • Global
From
AL Amyloidosis - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

AL Amyloidosis - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • March 2022
  • 166 Pages
  • Global
From
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 99 Pages
  • Global
From
Computer-Aided Drug Discovery Services Market, 2018-2030 - Product Thumbnail Image

Computer-Aided Drug Discovery Services Market, 2018-2030

  • Report
  • June 2018
  • 315 Pages
  • Global
From
Pharmaceutical Product & Preparations Manufacturing in Europe - Industry Market Research Report - Product Thumbnail Image

Pharmaceutical Product & Preparations Manufacturing in Europe - Industry Market Research Report

  • Report
  • November 2023
  • 16 Pages
  • Europe
From
Genmab A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Genmab A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Genmab AS (GMAB) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Genmab AS (GMAB) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • June 2024
  • 57 Pages
From
Loading Indicator